Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

19.36
Delayed Data
As of Jul 29
 -0.64 / -3.20%
Today’s Change
16.60
Today|||52-Week Range
21.49
-5.65%
Year-to-Date
VIVO Regular Dividend: VIVO will begin trading ex-dividend on 08/04/16 with a $0.20 dividend payable to shareholders of record as of 08/08/16.

Today’s Trading

Previous close20.00
Today’s open19.81
Day’s range19.08 - 19.86
Volume589,008
Average volume (3 months)219,226
Market cap$861.7M
Dividend yield4.13%
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+2.41%
Earnings growth (this year)+2.75%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+3.18%
P/E ratio23.0
Price/Sales3.69
Price/Book5.17

Competitors

 Today’s
change
Today’s
% change
AMAGAMAG Pharmaceuticals...-0.06-0.23%
QDELQuidel Corp-0.44-1.89%
NTRANatera Inc-0.18-1.36%
--Quidel Corp+1.94+10.41%
Data as of 3:59pm ET, 07/29/2016

Financials

Last reporting dateJuly 25, 2016
EPS forecast (this quarter)$0.22
Annual revenue (last year)$194.8M
Annual profit (last year)$35.5M
Net profit margin18.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John A. Kraeutler
EVP-Operations &
Information Systems
Lawrence J. Baldini
Corporate headquarters
Cincinnati, Ohio

Forecasts

Partner Offers

Search for Jobs